News – Page 436 – Endpoints News

Updated: Flagship sends a vet — post-Rubius implosion — into the breach at Repertoire

3 years ago

Insmed, Alnylam and others make Science's list of top 20 biopharma employers

3 years ago

N-of-1 CRISPR trial ends with a death as nonprofit digs into what happened

3 years ago

Teva reaches $523M agreement with New York in latest opioid-related settlement

3 years ago

Performer Teyana Taylor joins Joe Jonas in helping Merz 'ring the alarm' on frown lines

3 years ago

Novo Nordisk plots commercial relaunch for Wegovy as supplies are expected to return

3 years ago

Santhera lays out options in bid for commercialization funds; Swiss biotech’s Covid work narrows

3 years ago

FDA delays decision for Apellis' eye disease drug after biotech submits updated data

3 years ago

Three years after underwhelming data, Lieping Chen's NextCure drops lead program

3 years ago

Avanir files WARN notice for 100+ layoffs from California as merger with parent Otsuka looms

3 years ago

'Rulebook of microbial ecology': Pianists launch Concerto to treat eczema, protect crops and get rid of BO

3 years ago

Bayer drops an Ionis-partnered drug after sinking $240M into its development

3 years ago

Amgen on IRA's drug price negotiations: 'Material adverse effect' on sales, business and operations

3 years ago

After a one-year gap, Sage finally finds new CMO; Gutted by layoffs, Flagship's Rubius reshuffles a not-so-full deck

3 years ago

Sanofi, AstraZeneca clinch first OK for RSV antibody — just as vaccines line up at regulators

3 years ago

Exclusive: Mt. Everest almost got in the way of a tRNA biotech, but hC Bioscience climbs to Series A extension

3 years ago

Scoop: Calling off an IPO, a cancer and Covid-19 vaccine maker raises a Series C

3 years ago

'Forward, faster' and 200 jobs lighter as fibrosis and kidney disease get cut, Galapagos CEO Stoffels once again ...

3 years ago

Merck confronts stigma and fear around lung cancer screening in educational campaign

3 years ago

Regeneron culls two drugs from pipeline amid double-digit revenue drop after Covid mAb cocktail pull

3 years ago

With drug price negotiations in the books, Dems turn to launch prices as the next challenge

3 years ago

AstraZeneca pulls patient data exposed on code sharing site GitHub

3 years ago

Biopharma companies to FDA: Internationally harmonize plans to standardize safety data and analysis

3 years ago

FDA still not ready to go back to actual in-person meetings with biopharma sponsors

3 years ago

First page Previous page 433 434 435436437 438 439 Next page Last page